Noh Gyoung Tae, Han Jeonghee, Cheong Chinock, Han Yoon Dae, Kim Nam Kyu
Department of Surgery, Yonsei University College of Medicine, Seoul, Korea.
Ann Surg Treat Res. 2017 Oct;93(4):195-202. doi: 10.4174/astr.2017.93.4.195. Epub 2017 Sep 28.
Tumors at the level of the anorectal junction had required total levator-ani muscle excision to achieve an adequate resection margin. However, in the cases of tumor invading ipsilateral levator-ani muscle and intact external sphincter, en bloc resection of rectum with levator-ani muscle including tumor would be possible. This hemilevator excision (HLE) technique enables preserving the anal sphincter function while obtaining oncologic clearance and avoiding permanent colostomy in those patients. This study aimed to evaluate the surgical outcomes and feasibility of HLE.
Data on 13 consecutive patients who underwent HLE for pathologically proven low rectal cancer were retrospectively collected. All 13 patients presented low rectal cancer at the anorectal ring level that was suspected to invade or abut to the ipsilateral side of the levator-ani muscle.
A secure resection margin was achieved in all cases, and anastomotic leakage occurred in 2 patients. During follow-up, 3 patients experienced tumor recurrence (2 systemic and 1 local). Among 6 patients who underwent diverting ileostomy closure after the index operation, 2 complained of fecal incontinence. The other 4 patients without fecal incontinence showed <10 times of bowel movement per day. Accessing their incontinence scale, mean Wexner score was 9.4.
HLE is a novel sphincter-preserving technique that can be a treatment option for low rectal cancer invading ipsilateral levator-ani muscle, which has been an indication for abdominoperineal resection (APR) or extralevator APR. However, the long-term oncologic and functional outcomes of this procedure still need to be assessed to confirm its validity.
肛管直肠交界水平的肿瘤过去需要完全切除肛提肌以获得足够的切缘。然而,对于肿瘤侵犯同侧肛提肌且外括约肌完整的病例,整块切除包括肿瘤的直肠及肛提肌是可行的。这种半侧肛提肌切除术(HLE)技术能够在获得肿瘤学切缘的同时保留肛门括约肌功能,并避免这些患者进行永久性结肠造口术。本研究旨在评估HLE的手术效果和可行性。
回顾性收集了13例因病理证实为低位直肠癌而接受HLE手术的连续患者的数据。所有13例患者均表现为肛管直肠环水平的低位直肠癌,怀疑侵犯或紧邻同侧肛提肌。
所有病例均获得了安全的切缘,2例患者发生吻合口漏。在随访期间,3例患者出现肿瘤复发(2例为全身复发,1例为局部复发)。在初次手术后接受转流性回肠造口关闭术的6例患者中,2例主诉大便失禁。另外4例无大便失禁的患者每天排便次数<10次。根据他们的失禁量表,Wexner平均评分为9.4。
HLE是一种新型的保留括约肌技术,可作为侵犯同侧肛提肌的低位直肠癌的一种治疗选择,而侵犯同侧肛提肌过去一直是腹会阴联合切除术(APR)或扩大根治性APR的指征。然而,该手术的长期肿瘤学和功能结果仍需评估以证实其有效性。